Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Navigating the Diabetes Disease Landscape: Market Insight Epidemiology, Forecast, & Market Entry Strategies | Disease Landscape Insights


News provided by

Disease Landscape Insights

14 Sep, 2023, 14:29 GMT

Share this article

Share toX

Share this article

Share toX

Diabetes, a complex and pervasive metabolic disorder, poses a formidable challenge in today's healthcare landscape. As the global prevalence of diabetes continues to rise, the need for comprehensive understanding, innovative solutions, and effective healthcare services becomes increasingly critical. In this report, we delve deep into the multifaceted realm of diabetes, offering insights into its symptoms, diagnostic techniques, treatment gaps identification, and regulatory frameworks. At DiseaseLandscape Insights, a leading healthcare consulting services company, we are dedicated to providing invaluable assistance at each and every step of the journey.

LONDON, Sept. 14, 2023 /PRNewswire/ -- Diabetes, a chronic metabolic disorder characterized by high blood sugar levels, has emerged as a global healthcare challenge. As market researchers in the field of diabetes disease, it is crucial to provide insights into various aspects of this condition, from symptoms and diagnostic techniques to treatment options, regulatory consulting, and clinical trial management. This comprehensive report aims to shed light on the multifaceted aspects of diabetes, offering valuable information for patients, endocrinologist, healthcare professionals, and stakeholders in the diabetes industry.

Symptoms of Diabetes

Increased Thirst and Urination: Frequent thirst and urination are common early symptoms of diabetes. Excessive glucose in the bloodstream leads to increased urine production, resulting in dehydration and an unquenchable thirst.

Unexplained Weight Loss: Sudden and unexplained weight loss is often seen in individuals with uncontrolled diabetes, particularly in cases of type 1 diabetes. The body's inability to utilize glucose for energy leads to the breakdown of fat and muscle tissue leading to low blood sugar symptoms.

Fatigue: Persistent fatigue is another symptom of reverse diabetes, as high sugar level symptoms can disrupt the body's energy metabolism.

Blurry Vision: Elevated blood sugar levels can cause changes in the shape of the eye's lens, leading to blurry vision.

Slow Wound Healing: Individuals with diabetes may experience delayed wound healing due to impaired circulation and weakened immune function.

Price and Market Access

Ranges of Blood-Sugar Level

To diagnose and manage diabetes effectively, it is essential to understand the normal and target ranges for blood sugar levels:

Fasting Blood Sugar (FBS): A fasting blood sugar level below 100 mg/dL is considered normal, while levels between 100 and 125 mg/dL indicate prediabetes. A level of 126 mg/dL or higher on two separate tests indicates diabetes.

Postprandial Blood Sugar: Two hours after eating, blood sugar levels should be less than 140 mg/dL. Levels between 140 and 199 mg/dL suggest prediabetes, while levels above 200 mg/dL indicate diabetes.

Causes of Diabetes

Diabetes is a complex condition with multiple contributing factors. The primary causes include:

Genetics: Family history plays a significant role in diabetes risk. Certain genes can predispose individuals to the condition.

Lifestyle Factors: Sedentary lifestyles, poor dietary choices, and obesity are key risk factors for type 2 diabetes.

Autoimmune Response: In type 1 diabetes, the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas.

Diabetes & its Types

There are primarily two types of diabetes:

Type 1 Diabetes: This autoimmune condition typically develops in childhood or adolescence and is characterized by the body's inability to produce insulin. Individuals with type 1 diabetes require lifelong insulin therapy.

Type 2 Diabetes: The most common signs of type 2 diabetes typically occurs in adulthood and is associated with signs of insulin resistance and insulin resistance test. It can often be managed through lifestyle changes, medications, and, in some cases, insulin therapy.

Learn More About the FDA NDA & BLA Approval (NME) Drugs for Diabetes Disease @

https://www.diseaselandscape.com/requestsample/postid/71

Diagnostic Techniques for Diabetes

Accurate diagnosis is crucial for effective diabetes management. Common diagnostic tests include:

  • Fasting Blood Sugar Test: Measures blood sugar levels after an overnight fast.
  • Oral Glucose Tolerance Test (OGTT): Evaluates blood sugar levels before and after consuming a glucose solution (glucose blood test)
  • Hemoglobin A1c levels Test: Reflects average blood sugar levels over the past two to three months.

Diabetes Treatment Techniques

Treatment strategies for diabetes overview and diabetes medications depend on the type and severity of the condition. They include:

  • Lifestyle Modifications: Encouraging a balanced diet, regular exercise, and weight management.
  • Oral Medications: For type 2 diabetes, medications may be prescribed to improve insulin sensitivity or stimulate insulin production.
  • Insulin Therapy: Individuals with type 1 diabetes and some with type 2 diabetes symptoms may require insulin injections or insulin pumps.

Regulatory Framework for Diabetes Disease

Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), play a crucial role in overseeing diabetes-related treatments and medications. These agencies evaluate the safety and efficacy of new drugs as well as drug development and therapies through rigorous clinical trials.

Clinical Trial Assessment

Clinical trials are essential for advancing diabetes treatment and understanding the disease landscape better. They help assess the effectiveness and safety of new treatments, devices, and therapies. Researchers, healthcare professionals, and regulatory authorities closely monitor these trials to ensure patient safety and the development of innovative solutions as well as drug launch strategies.

Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @

https://www.diseaselandscape.com/downloadsample/postid/71

Final Words

Diabetes remains a significant global health challenge, affecting millions of people worldwide. As market researchers, it is vital to stay updated on the latest developments in diabetes care, from symptoms and diagnostic techniques to treatment options and regulatory frameworks. By fostering innovation, research, and patient care, we can work together to improve the lives of those living with diabetes and reduce its prevalence in the future.

Browse Through More Chronic Disease Research Reports.

Related Reports:

  • Prognosis, market-entry, and prevention information on the HPV Disease
  • Navigating the Complex Autoimmune Disorder of Lupus
  • Ringworm Comprehensive Guide: Symptoms, Causes, and Treatment
  • The symptoms, transmission, and precautions of Monkeypox
  • Diverticulitis: A Complete Guide to the Symptoms, Causes, and Treatments
  • Insights and Trends in the Global Lung Cancer Services
  • Insights on the HPV Disease, Market Entry, Prognosis, and Prevention
  • Understanding Lupus: Navigating the Complex Autoimmune Disorder
  • Comprehensive Guide to Ringworm: Symptoms, Causes, and Effective Treatment
  • Monkeypox Unveiled: Symptoms, Transmission, and Preventive Measures
  • Comprehensive Guide to Diverticulitis: Symptoms, Causes, and Solutions
  • Global Landscape of Lung Cancer Services: Insights and Trends

About Disease Landscape: 

Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods.  

Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research.  

Contact Us:  

Disease Landscape Insights LLP  
6th Floor, Sr No.207, Office A H 6070 Phase 1  
Solitaire Business Hub, Viman Nagar 
Pune, Maharashtra, 411014  
Email: ajay@diseaselandscape.com    
Email: vishal@diseaselandscape.com  
Corporate Sales: +44-2038074155  
Asia Office: +917447409162
Blog: https://www.diseaselandscape.com/blogs  
Case Study: https://www.diseaselandscape.com/casestudies  
Pharma consulting Services  
Follow Us: LinkedIn | Twitter | Facebook

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.